Senior Clinical Research Associate
Anteris Technologies
Senior Clinical Research Associate
Anteris Technologies
Transcatheter heart valves for aortic stenosis
Anteris® Technologies is a global structural heart company dedicated to revolutionizing cardiac care. With offices in Minneapolis, MN, US; Geneva, Switzerland; and Brisbane and Perth, Australia, we have a growing and inclusive team.
Our mission is to forge new frontiers in cardiac care by pioneering science-driven and measurable advancements to restore heart valve patients to healthy function. Transcatheter Aortic Valve Replacement (TAVR) technologies were originally designed for older, high-risk patients. Today, younger, more active patients need a better solution that will not just open and close but restore healthy heart function. We seek to restore healthy blood flow patterns by creating the world’s first biomimetic TAVR valve, DurAVR® THV. This cutting-edge valve, incorporating our proprietary ADAPT® anti-calcification technology, is designed to mimic the natural function of a healthy heart valve.
The Senior Clinical Research Associate (CRA) will play a key role in the execution of our global PARADIGM pivotal trial, ensuring the highest standards of clinical quality, data integrity, patient safety, and regulatory compliance.
This role combines hands-on clinical site management and monitoring with sponsor-level oversight of CROs, contract CRAs, and clinical vendors. Responsibilities span the full clinical trial lifecycle, including site qualification, budget and clinical trial agreement negotiations, site activation, enrollment, monitoring, inspection readiness, and study closeout.
The ideal candidate brings direct TAVR clinical trial experience, strong independent site management capabilities, and the ability to build collaborative relationships with investigators, research teams, and external partners in a fast-paced, pre-commercial medical device environment.
At Anteris® Technologies, you’ll join a team committed to improving the lives of patients with aortic stenosis through groundbreaking structural heart solutions. This is an opportunity to make a measurable impact on patient outcomes while shaping the future of heart valve innovation.
Location: Remote, United States
Key Responsibilities:
Required Skills, Knowledge, Experience & Qualifications:
Preferred Skills, Knowledge, Experience & Qualifications:
Work Environment & Physical Requirements:
Compensation:
Target base salary range: $120,000–$145,000 + 8.5% annual bonus & equity. Final compensation will be based on experience and alignment with role requirements. Unfortunately, we are unable to provide employment-based visa sponsorship or support OPT employment at this time.
What We Offer:
Health and Wellness Offerings:
Note: We may require proof of COVID-19 vaccination to comply with health institutions, state, local municipality, and/or travel regulations.
Anteris Technologies recruits, employs, trains, compensates, and promotes regardless of race, religion, color, national origin, sex, disability, age, veteran status, and other protected status as required by applicable law. We have a clear vision: to be a place of belonging for all humans by promoting diversity, multiculturism and inclusion, as a goal and reflection across the organization. Diversity is more than a commitment - it is part of our mission to deliver the best structural heart products on a global scale.
Transcatheter heart valves for aortic stenosis
Anteris Technologies designs and sells heart valve systems for structural heart diseases, with a focus on aortic stenosis. Its flagship DurAVR Transcatheter Heart Valve (TAVR) system is delivered via a minimally invasive catheter, replacing a diseased aortic valve without open-heart surgery. The valve uses ADAPT treated tissue and a 3D single-piece design to create a durable valve that resists calcification for over 10 years. This makes its products suitable for hospitals and patients seeking safer, quicker recovery compared to traditional surgery. The company differentiates itself with its proprietary anti-calcification ADAPT tissue and its unique one-piece 3D valve design, aiming to provide long-lasting valve durability in the growing transcatheter market. Its goal is to improve patient outcomes through durable, minimally invasive heart valve solutions and to expand its share in the global medical devices market for aortic stenosis.
Explore more opportunities at Anteris Technologies